Capital Flow Monitor · Sponsors · CIK 2074593
PridCor Therapeutics, LLC
1837 COMMONS NORTH DRIVE, TUSCALOOSA, AL, 35406 · 2053660696
Pharmaceuticals · Limited Liability Company· inc. ALABAMA true 2025
Fit score
—
Offering
$6.0M
Sold
$0
% sold
0.0%
Investors
0
Min investment
$20K
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-07-06 | D/A ·current | 506(b) | $6.0M | $0 | 0.0% | 0 | EDGAR ↗ |
| 2026-05-08 | D | 506(c) | $6.0M | $0 | 0.0% | 0 | EDGAR ↗ |
| 2026-02-02 | D | 506(c) | $1.0M | $0 | 0.0% | 0 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- William L Pridgen — Executive Officer / Promoter, Tuscaloosa, AL
- Brian Corday — Executive Officer / Promoter, Johns Creek, GA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.